Genesis Research and SIRIUS Market Access form Trans-Atlantic market access collaboration

HOBOKEN, N.J. - March 18, 2019 - PRLog -- GENESIS RESEARCH ("GENESIS") and SIRIUS Market Access Ltd ("SIRIUS Market Access"), research and consulting companies providing value evidence strategy, development, and communication solutions to the Life Sciences industry, today announced a trans-Atlantic collaboration. Through a partnership approach, GENESIS and SIRIUS will drive further value to clients through a comprehensive range of global HEOR, market access, and data analytics capabilities, with expanded geographical expertise, and a deep understanding of US and EU real world evidence sources.

Founded in 2009, GENESIS is a company that brings a holistic perspective to Healthcare Evidence strategy, development, and communication. Categorizing evidence as foundational, demonstrative or oppositional in nature, GENESIS engages manufacturers of novel medical technologies with customized solutions across Real World Evidence Analytics, Outcomes Research and Scientific Communications.

SIRIUS Market Access were founded in 2013 and specialise in partnering with clients to create ground-breaking global market access strategies and value platforms, developing bespoke supportive evidence to demonstrate product value and communicating value with innovative tools and dossiers.

Steve Arikian, MD, Chief Executive Officer of Genesis, commented, "With this exciting collaboration, we have a unique ability to integrate our complementary capabilities and geographic footprints to provide enhanced solutions to make every day easier for our clients. We will enable our clients to leverage the full power of both companies, driving innovation and building intelligent, connected customer experiences. Our firms are aligned culturally and philosophically, and our clients will experience an expanded service offering in a seamless manner due to our shared fiduciary heritage and values that place the client at the forefront of everything we do."

Stephen Ralston, partner at SIRIUS Market Access, said, "Working with GENESIS will allow SIRIUS to support our clients with specific expertise in markets outside of our current scope. We have always focused on our strengths; understanding global development and how we can support our clients in developing specific evidence to support the European markets. This collaboration will allow us to integrate our expertise with developing value and solutions to also support the US market."

About GENESIS RESEARCH

Genesis Research is research and consulting company to the Life Sciences industry that delivers real world evidence to satisfy regulatory, payor, and commercial requirements throughout the product life-cycle. As a leader in evidence development and communication, GENESIS also supports clients with unique services such as rapid response analytics, outcomes simulation, and payer data collaboration. For more information about GENESIS, please visit www.GenesisRG.com.

About SIRIUS Market Access:

SIRIUS Market Access provide leading market access services to the pharmaceutical and therapeutic industry, both in the UK and worldwide. Our goal is to increase and develop the value of your products and clearly communicate it to your key audience.

SIRIUS bring a new level of expertise in market access, HTA, and value communications. Established in 2013, SIRIUS are a team of experts dedicated to delivering a new level of focused attention, understanding value, developing value and communicating value. We partner with our clients to build value for their products and communicate this clearly and with impact. For more information on SIRIUS Market Access, please visit www.siriusmarketaccess.com.

CONTACT

Alistair Curry, SIRIUS Market Access, at acurry@siriusmarketaccess.com

Karl Freemyer, Genesis Research, at Karl@GenesisRG.com